Related Experiment Video
Updated: Aug 2, 2026
07:01
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
Expression of S100A2 and S100A6 in thyroid carcinomas
Histopathology
|April 22, 2005
Summary
S100A2 and S100A6 proteins show unique expression patterns in thyroid neoplasms. These findings suggest their involvement in papillary and anaplastic carcinoma development.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- S100 calcium-binding proteins are implicated in various carcinoma development pathways.
- Understanding specific S100 protein roles in thyroid cancer is crucial for diagnosis and treatment.
Purpose of the Study:
- To investigate the expression patterns of S100A2 and S100A6 in different types of thyroid neoplasms.
- To determine the potential role of these proteins in thyroid cancer progression.
Main Methods:
- Immunohistochemistry was used to analyze S100A2 and S100A6 expression.
- The study included 141 thyroid neoplasms, encompassing normal tissue, follicular tumors, papillary carcinomas, and anaplastic carcinomas.
Main Results:
- S100A2 was largely absent in normal thyroid tissue and follicular tumors but frequently expressed in papillary and anaplastic carcinomas.
- S100A6 showed low expression in normal follicles, with increased levels in follicular adenomas and carcinomas, but decreased expression in anaplastic carcinomas.
Conclusions:
- The distinct expression profiles of S100A2 and S100A6 in thyroid neoplasms differ from other carcinomas.
- S100A2 and S100A6 likely contribute to papillary carcinoma progression.
- S100A2 expression serves as a biological marker for anaplastic carcinoma.
